|
Protein Sciences Corporation is a vaccine company focused primarily on using modern technology to make the next generation of safer and more effective human and animal vaccines for influenza, SARS and other diseases. We develop all of our products internally and own commercialization rights to these products. Our service businesses manufacture pharmaceutical and research proteins and products for customers.
Visit us at the BIO International Convention, Boston, Massachusetts May 6th - May 9th Booth# 1179
 |
 |
|
 Our GENEXPRESS® service business is used to develop and manufacture pharmaceutical and research proteins for customers.
|
|
|
 |
 |
We have a pipeline of patented products that include two influenza vaccines that have completed Phase II(b) human clinical trials, one of which, FluBlØk™ is scheduled to enter pivotal Phase III trials in the fall of 2004. Our SARS vaccine and erythropoietin have completed animal tests and will enter human testing soon.
|
 |
 |
Our products include complex proteins for research use, our patented serum-free expresSF+® cells, and the GeneXpress BaculoKIT™, our baculovirus protein expression kit.
|
|
|
